v3.25.2
Additional Information to the Items of Profit or Loss (Tables)
 12 Months Ended
Dec. 31, 2024
Additional Information to the Items of Profit or Loss [Abstract]  
Schedule of Additional Information to the Items of Profit or Loss
     Year ended December 31, 
     2024   2023   2022 
a. Research and development expenses:            
  Wages and related expenses  $390   $392   $436 
  Share-based payment   45    34    264 
  Regulatory, professional and other expenses   681    719    750 
  Research and preclinical studies   211    101    703 
  Clinical studies   276    254    369 
  Chemistry and formulations   104    141    281 
                  
      1,707    1,641    2,803 
                  
b. Sales and marketing expenses:               
  Advertising  $367   $576   $363 
  Amazon fees   495    1,042

*

   454*
  Depreciation   366    486    144 
  Storage and shipping   167    145

*

   91*
  Management fees   120    235    30 
                  
      1,515    2,484    1,082 
                  
c. General and administrative expenses:               
  Wages and related expenses   507    415    437 
  Share-based payment   419    68    633 
  Professional and directors’ fees   3,009    2,594    2,468 
  Business development expenses   108    86    161 
  Regulatory expenses   158    202    162 
  Office maintenance, rent and other expenses   128    110    80 
  Investor relations and business expenses   197    369    1,486 
                  
      4,526    3,844

*

   5,427 
                  
d. Other expenses (income):               
  Loss from sale of property and equipment   17    
-
    
-
 
  Gain on sale of patent license, net (net of Polyrizon Ltd. holdings sold) (See also Note 25b)   (1,287)   
-
    
-
 
      (1,270)   
-
    
-
 
                  
e. Finance income:               
  Net change in fair value of financial liabilities designated at fair value through profit or loss   (191)   (2,205)   (7,832)
  Interest from loans to related parties and deposits   (421)   
-
    
-
 
  Exchange rate differences, net   
-
    (14)   
-
 
                  
      (612)   (2,219)   (7,832)
f. Finance expenses:               
  Issuance expenses related to warrants   
-
    
-
    1,204 
  Exchange rate differences, net   18    
-
    4 
  Losses from remeasurement of investment in financial assets   305    1,046    770 
  Finance expense in respect of leases   8    9    15 
  Finance expenses from interest and commissions   22    
-
    21 
                  
     $353   $1,055   $2,014 

 

(*)Reclassified